These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 31368789)

  • 21. [From Evidence to Health Policy Making: Pre-Exposure Prophylaxis for HIV Prevention].
    Ko NY
    Hu Li Za Zhi; 2016 Dec; 63(6):18-22. PubMed ID: 27900741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From subjects to relations: Bioethics and the articulation of postcolonial politics in the Cambodia Pre-Exposure Prophylaxis trial.
    Grant JM
    Soc Stud Sci; 2016 Apr; 46(2):236-58. PubMed ID: 27263238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancing independent adolescent consent for participation in HIV prevention research.
    Shah SK; Allison SM; Kapogiannis BG; Black R; Dawson L; Erbelding E
    J Med Ethics; 2018 Jul; 44(7):431-433. PubMed ID: 29895555
    [No Abstract]   [Full Text] [Related]  

  • 25. 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.
    Guise A; Albers ER; Strathdee SA
    Addiction; 2017 Apr; 112(4):572-578. PubMed ID: 27273843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants.
    Fernandez Lynch H
    Bioethics; 2020 Nov; 34(9):923-932. PubMed ID: 32091138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organ donor intervention trials and risk to bystanders: An ethical analysis.
    Cohen IG
    Clin Trials; 2019 Oct; 16(5):463-465. PubMed ID: 31368791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.
    Freeborn K; Portillo CJ
    J Clin Nurs; 2018 Sep; 27(17-18):3254-3265. PubMed ID: 28771856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review.
    Kamitani E; Johnson AH; Wichser M; Mizuno Y; DeLuca JB; Higa DH
    BMJ Open; 2019 May; 9(5):e024212. PubMed ID: 31129574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical considerations in HIV prevention and vaccine research in resource-limited settings.
    Garner SA; Anude CJ; Adams E; Dawson L
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):77-83. PubMed ID: 25117930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protecting sexual minority youth from research risks: conflicting perspectives.
    Miller RL; Forte D; Wilson BD; Greene GJ
    Am J Community Psychol; 2006 Jun; 37(3-4):341-8. PubMed ID: 16775774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against discrimination based on HIV/AIDS status in Canada: the legal framework.
    Elliott R; Gold J
    HIV AIDS Policy Law Rev; 2005 Apr; 10(1):20-31. PubMed ID: 15991367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethical public health issues for the use of informal PrEP.
    Brisson J
    Glob Public Health; 2018 Oct; 13(10):1382-1387. PubMed ID: 28868979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.
    Balzer L; Staples P; Onnela JP; DeGruttola V
    Clin Trials; 2017 Apr; 14(2):201-210. PubMed ID: 28124579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical issues in HIV/AIDS research.
    Muthuswamy V
    Indian J Med Res; 2005 Apr; 121(4):601-10. PubMed ID: 15817966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
    Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
    Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Women's Health Care in the United States.
    Seidman D; Weber S
    Obstet Gynecol; 2016 Jul; 128(1):37-43. PubMed ID: 27275793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.
    Nikolopoulos GK; Christaki E; Paraskevis D; Bonovas S
    Curr Pharm Des; 2017; 23(18):2579-2591. PubMed ID: 28356043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.
    Hillis A; Germain J; Hope V; McVeigh J; Van Hout MC
    AIDS Behav; 2020 Nov; 24(11):3056-3070. PubMed ID: 32274670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.